Exchange transfusion safety and outcomes in neonatal hyperbilirubinemia.,Journal of Perinatology

当前位置： X-MOL 学术 › J. Perinatol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Exchange transfusion safety and outcomes in neonatal hyperbilirubinemia.
Journal of Perinatology ( IF 2.4 ) Pub Date : 2020-03-09 , DOI: 10.1038/s41372-020-0642-0
Mattie F Wolf ₁ , Julie Childers ₁ , Keyaria D Gray ₁ , Caroline Chivily ₂ , Mike Glenn ₂ , Laila Jones ₂ , Mini Kpa ₂ , Taylor McMannen ₂ , Isaias Reyes ₂ , Kanecia O Zimmerman _{1,

2} , Reese H Clark ₃ , Rachel G Greenberg _{1,

2}

Affiliation

Objective

To characterize the prevalence of exchange transfusion (ET), clinical characteristics of infants receiving ET, and ET-associated morbidity and mortality.

Study design

We conducted a multicenter cohort study of infants ≥23 weeks of gestational age (GA) with hyperbilirubinemia who underwent ET within 30 days of birth from 1997 to 2016. We examined clinical characteristics and adverse events after ET. We used multivariable logistic regression to examine the association between clinical risk factors and death.

Result

A total of 1252 infants were included; 4% died within 7 days of ET and 6% died before discharge. Compared with infants ≥37 weeks of GA, infants ≤29 weeks of GA had greater odds of death (adjusted odds ratio [95% confidence interval] = 20.08 [7.32, 55.07]).

Conclusions

Infants ≤ 29 weeks of GA had greater odds of death following ET compared with term infants. These data will support clinicians in evaluating risks and prognosis for infants who require ET.

中文翻译：